SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Agilyx ASA (AGXXF) , forward earnings yield 4.03%. PEG 0.22 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 24.8
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AGXXF
Valuation Multiples
P/E (TTM)0.0
Forward P/E24.8
PEG Ratio0.22
Forward PEG0.22
P/B Ratio0.00
P/S Ratio164.50
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.23
Forward EPS (Est.)$0.07
Book Value / Share$0.00
Revenue / Share$0.01
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield4.03%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-0.07 |
$2.5M |
$-2.53M |
-101.1% |
| 2019 |
$-0.21 |
$2.06M |
$-7.22M |
-351.1% |
| 2020 |
$-0.14 |
$4.34M |
$-10.14M |
-233.8% |
| 2021 |
$-0.21 |
$4.89M |
$-16.24M |
-332.2% |
| 2022 |
$-0.29 |
$16.46M |
$-23.38M |
-142.1% |
| 2023 |
$-0.25 |
$5.89M |
$-21.52M |
-365.1% |
| 2024 |
$-0.23 |
$1.01M |
$-22.04M |
-2182.5% |